SLP-2对前列腺癌PC-3细胞增殖和早期凋亡的影响 |
| |
引用本文: | 邓玮明,何娅娣,李科,张凌霄,方友强,高新,李辽源.SLP-2对前列腺癌PC-3细胞增殖和早期凋亡的影响[J].中华腔镜泌尿外科杂志(电子版),2014(1):50-53. |
| |
作者姓名: | 邓玮明 何娅娣 李科 张凌霄 方友强 高新 李辽源 |
| |
作者单位: | [1]中山大学附属第三医院泌尿外科,广州510630 [2]中山大学附属第三医院体检中心,广州510630 |
| |
基金项目: | 国家自然科学基金(81001139,81202012) |
| |
摘 要: | 目的探讨SLP-2(stomatin-like protein2)基因对人前列腺癌PC-3细胞增殖和凋亡的影响。方法合成和构建SLP-2沉默和过表达载体,用Lipofectamine TM2000分别转染5组人前列腺癌PC-3细胞:pcDNA3.1-SLP-2组,空质粒pcDNA3-1组,siRNA—SLP-2组,siRNA阴性对照组以及空白对照组。采用Q-PCR和Western-Blot分别检测PC-3细胞中SLP-2的mRNA和蛋白表达量;用细胞计数试剂盒(CCK-8)检测PC-3细胞增殖;采用细胞线粒体膜电位JC-1试剂盒检测PC-3细胞的早期凋亡情况。结果转染pcDNA3.1-SLP-2质粒和siRNA-SLP-2后PC-3细胞SLP.2基因mRNA表达水平分别为(324.884±16.508)和(0.195±0.016),蛋白表达水平分别为(5.013±0.284)和(0.296±0.011),与空白对照组相比差异均有统计学意义(P〈0.05);转染pcDNA3-1-SLP-2基因48h、72h、96h后Pc。3细胞增殖吸光度值(OD值)分别为(0.714±0.007)、(1.103±0.018)、(1.348±0.018),均显著高于空白对照组(P〈0.05)。采用siRNA沉默SLP.2基因48h、72h、96h后PC-3细胞增殖率分别为(0.571±0.004)、(0.875±0.010)、(1.044±0.008),均显著低于空白对照组(P〈0.05);细胞凋亡结果显示,转染pcDNA3.1-SLP.2和siRNA-SLP-2的PC-3细胞早期凋亡率分别为(2.433±0.577)和(9.197±0.602),与空白对照组(4.993±0.710)相比差异均有统计学意义(P〈0.05)。结论SLP-2可促进人前列腺癌PC-3细胞的增殖,并抑制细胞的早期凋亡。
|
关 键 词: | SLP-2 前列腺癌 PC-3细胞 增殖 凋亡 |
The effect of SLP-2 on the cell proliferation and early apoptosis in PC-3 cells line of prostate cancer |
| |
Authors: | Deng Weiming He Yadi Li Ke Zhang Lingxiao Fang Youqiang Gao Xin Li Liaoyuan |
| |
Institution: | . Department of Urology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China |
| |
Abstract: | Objective To explore the effect of SLP-2 on cell proliferation and early apoptosis in PC-3 cells line of prostate cancer. Methods The pcDNA3.1-SLP-2 and siRNA-SLP-2 were constructed and transfected into PC-3 cells by LipofectamineTM 2000 in 5 groups: pcDNA3.1-SLP-2, pcDNA3.1, siRNA-SLP-2, mock siRNA, and blank control. Q-PCR and Western blot were used to detect the expression of SLP-2 mRNA and protein, CCK-8 kit was used to detect cell proliferation, and MMP (mitochondrial membrane potential) JC-1 kit for cell apoptosis determination. Results The mRNA expression levels of SLP-2 in pcDNA3.1-SLP-2 and siRNA-SLP-2 were (324.884±16.508) and (0.195±0.016), respectively. The protein expression levels were (5.013±0.284) and (0.296±_0.011), respectively. There were statistical significance in both mRNA and protein expression levels of SLP-2 between these two groups and blank control group (P〈0.05). The OD values in pcDNA3.1-SLP-2 group were (0.714±0.007), (1.103±0.018), (1.348±0.018), respectively, at 48, 72, 96 h after transfection, which were significantly higher than those of the blank control. The OD values in siRNA-SLP-2 group were (0.571±0.004), (0.875±0.010), (1.044±0.008),respectively, at 48, 72, 96 h after transfection, which were significantly lower than those of the blank control. The cell apoptosis assay showed that the early apoptosis rates of pcDNA3.1-SLP-2 and siRNA-SLP-2 were (2.433±0.577) and (9.197±0.602), respectively. There were statistical significance in the early apoptosis rates between these two groups and blank control group (P〈0.05). Conclusion SLP-2 could promote cell proliferation and inhibit the early cell apoptosis of PC-3 cell line. |
| |
Keywords: | Stomatin-like protein 2 Prostate cancer PC-3 cells Proliferation Apoptosis |
本文献已被 维普 等数据库收录! |
|